GSDMD通过调节GATA2/AQP4信号通路来调节Ang II诱导的高血压脏病
Xiaoxi Fan1,2, Wenli Zhang2,3, Ruihan Zheng1
1The Key Laboratory of Cardiovascular Disease of Wenzhou, Department of Cardiology, the First Affiliated Hospital of Wenzhou Medical University, Zhejiang, People's Republic of China.
加斯德明D (GSDMD) 在高血压脏病中驱动损伤. 抑制GSDMD或其缺陷可以防止这种情况,提供潜在的治疗点.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 分子生物学分子生物学
- 病理学 病理学 病理学
背景情况:
- 高血压性病是高血压的常见并发症,对功能不全没有有效的预防措施.
- 加斯德明D (GSDMD) 是热的关键调解剂,已知可诱导显著的炎症反应.
研究的目的:
- 调查GSDMD在高血压脏病的发病过程中的作用.
- 探索GSDMD作为治疗高血压脏病的潜在治疗标.
主要方法:
- 在野生型和Gsdmd淘汰赛小鼠中使用血管素II (Ang II) 输液建立了高血压损伤模型.
- 使用了GSDMD过度表达模型,并评估了功能,组织病理学,炎症和纤维化.
- 采用转录组测序 (RNA-seq) 和CUT&Tag来阐明下游机制.
主要成果:
- 在管状上皮细胞中观察到GSDMD的激活,作为对Ang II的反应.
- GSDMD缺陷减弱,而过度表达加剧了Ang II诱导的损伤和纤维化.
- GSDMD促进了GATA结合蛋白2 (GATA2) 转录,这反过来又调节了aquaporin 4 (Aqp4) 表达,导致损伤.
结论:
- GSDMD在高血压脏病的发展中发挥着重要作用.
- 向GSDMD为管理高血压脏病提供了一个有希望的治疗策略.
更多相关视频
10:09Drug Treatment by Central Venous Catheter in a Mouse Model of Angiotensin II Induced Abdominal Aortic Aneurysm and Monitoring by 3D Ultrasound
Published on: August 4, 2022
08:15Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
Published on: May 10, 2024
相关概念视频
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Antihypertensive Drugs: Direct Renin Inhibitors
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Endocrine Signaling
Glomerular Filtration Rate and its Regulation
GFR regulation involves two primary intrinsic controls: the myogenic and tubuloglomerular feedback mechanisms.
The myogenic...
